Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Outline of critical factors to assess before buying crypto, focusing on fundamentals, market context, and prudent decision-making.
26,392 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Conagra Brands is pouring $220 million into a key manufacturing upgrade, signaling confidence in demand. But does tha...
Oil hovers above $100 as the U.S. weighs a potential ground war in Iran. The move could ripple through gas prices, in...
AI stocks have pulled back, but the fundamental machine beneath the hype is still growing. Learn why forget sell-off:...
Horizon (HRZN) investors want clarity on Q3 2025 results and what comes next. This article breaks down horizon (hrzn)...
A practical guide to Warner Music’s 2026 outlook for investors. Explore growth drivers, margins, and the risks that c...
RadNet is entering 2026 with a mix of imaging volumes, payer dynamics, and technology investments. This guide breaks ...
A major fund sold almost 230k ANIP shares in Q1, triggering volatility in the pharma stock. This article breaks down ...
If you rely on Social Security, the 2027 COLA forecast isn't just a number—it's a planning tool. This article breaks ...
A landmark $1.5 billion bet on counter-drone tech sets Motorola Solutions up for deeper public-safety leadership. Her...
As a rare-earth supplier with the United States' only large-scale mine, MP Materials sits at a pivotal crossroads. If...
A trusted market voice pivots from saying there’s no bubble to warning of growing chaos as IPO activity accelerates a...